DDX11 and melanoma: The biochemical functions of DDX11 have been established[20], but hitherto, a DDX11-specific small-molecule inhibitor is not available that would make it possible to systemically treat human melanoma xenografts and establish in vivo, therapeutic efficacy of blocking the function of DDX11.